Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014
Upcoming SlideShare
Loading in...5
×
 

Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014

on

  • 349 views

This report provides comprehensive information on the current therapeutic developmental pipeline of Salix Pharmaceuticals Ltd.s, complete with comparative analysis at various stages, therapeutics ...

This report provides comprehensive information on the current therapeutic developmental pipeline of Salix Pharmaceuticals Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Get Detail Report With TOC @ http://www.researchmoz.us/salix-pharmaceuticals-ltd-product-pipeline-review-2014-report.html

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Statistics

Views

Total Views
349
Views on SlideShare
349
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014 Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014 Document Transcript

  • Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014 Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014 Summary Global Markets Directs, Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014, provides an overview of the Salix Pharmaceuticals Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Salix Pharmaceuticals Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Salix Pharmaceuticals Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Salix Pharmaceuticals Ltd.s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Salix Pharmaceuticals Ltd.s pipeline products Reasons to buy - Evaluate Salix Pharmaceuticals Ltd.s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Salix Pharmaceuticals Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Salix Pharmaceuticals Ltd.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Salix Pharmaceuticals Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Salix Pharmaceuticals Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Salix Pharmaceuticals Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 4 salix Pharmaceuticals Ltd. Snapshot 5 salix Pharmaceuticals Ltd. Overview 5 key Information 5 key Facts 5 salix Pharmaceuticals Ltd. - Research And Development Overview 6 key Therapeutic Areas 6 salix Pharmaceuticals Ltd. - Pipeline Review 8 pipeline Products By Stage Of Development 8 pipeline Products - Monotherapy 9 pipeline Products - Partnered Products 10 partnered Products/combination Treatment Modalities 11 Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014
  • salix Pharmaceuticals Ltd. - Pipeline Products Glance 12 salix Pharmaceuticals Ltd. - Late Stage Pipeline Products 12 pre-registration Products/combination Treatment Modalities 12 phase Iii Products/combination Treatment Modalities 13 salix Pharmaceuticals Ltd. - Clinical Stage Pipeline Products 14 phase Ii Products/combination Treatment Modalities 14 salix Pharmaceuticals Ltd. - Drug Profiles 15 budesonide 15 product Description 15 mechanism Of Action 15 r&d Progress 15 methylnaltrexone Bromide 18 product Description 18 mechanism Of Action 18 r&d Progress 18 rifaximin 21 product Description 21 mechanism Of Action 21 r&d Progress 21 budesonide Er 23 product Description 23 mechanism Of Action 23 r&d Progress 23 rhb-106 25 product Description 25 mechanism Of Action 25 r&d Progress 25 san-300 26 product Description 26 mechanism Of Action 26 r&d Progress 26 salix Pharmaceuticals Ltd. - Pipeline Analysis 27 salix Pharmaceuticals Ltd. - Pipeline Products By Target 27 salix Pharmaceuticals Ltd. - Pipeline Products By Route Of Administration 28 salix Pharmaceuticals Ltd. - Pipeline Products By Molecule Type 29 salix Pharmaceuticals Ltd. - Pipeline Products By Mechanism Of Action 30 salix Pharmaceuticals Ltd. - Recent Pipeline Updates 31 salix Pharmaceuticals Ltd. - Dormant Projects 39 salix Pharmaceuticals Ltd. - Company Statement 40 salix Pharmaceuticals Ltd. - Locations And Subsidiaries 42 head Office 42 other Locations & Subsidiaries 42 appendix 44 methodology 44 coverage 44 secondary Research 44 primary Research 44 expert Panel Validation 44 contact Us 45 disclaimer 45 list Of Tables salix Pharmaceuticals Ltd., Key Information 5 salix Pharmaceuticals Ltd., Key Facts 5 salix Pharmaceuticals Ltd. - Pipeline By Indication, 2014 7 salix Pharmaceuticals Ltd. - Pipeline By Stage Of Development, 2014 8 salix Pharmaceuticals Ltd. - Monotherapy Products In Pipeline, 2014 9 salix Pharmaceuticals Ltd. - Partnered Products In Pipeline, 2014 10 salix Pharmaceuticals Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11 salix Pharmaceuticals Ltd. - Pre-registration, 2014 12 salix Pharmaceuticals Ltd. - Phase Iii, 2014 13 salix Pharmaceuticals Ltd. - Phase Ii, 2014 14 salix Pharmaceuticals Ltd. - Pipeline By Target, 2014 27 salix Pharmaceuticals Ltd. - Pipeline By Route Of Administration, 2014 28 salix Pharmaceuticals Ltd. - Pipeline By Molecule Type, 2014 29 salix Pharmaceuticals Ltd. - Pipeline Products By Mechanism Of Action, 2014 30 salix Pharmaceuticals Ltd. - Recent Pipeline Updates, 2014 31 salix Pharmaceuticals Ltd. - Dormant Developmental Projects,2014 39 Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014
  • salix Pharmaceuticals Ltd., Subsidiaries 42 list Of Figures salix Pharmaceuticals Ltd. - Pipeline By Top 10 Indication, 2014 7 salix Pharmaceuticals Ltd. - Pipeline By Stage Of Development, 2014 8 salix Pharmaceuticals Ltd. - Monotherapy Products In Pipeline, 2014 9 salix Pharmaceuticals Ltd. - Partnered Products In Pipeline, 2014 10 salix Pharmaceuticals Ltd. - Pipeline By Top 10 Target, 2014 27 salix Pharmaceuticals Ltd. - Pipeline By Top 10 Route Of Administration, 2014 28 salix Pharmaceuticals Ltd. - Pipeline By Top 10 Molecule Type, 2014 29 salix Pharmaceuticals Ltd. - Pipeline Products By Top 10 Mechanism Of Action, 2014 30 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014